Dr. Paul Brunetta, MD is a co-founder of the UCSF Fontana Tobacco Treatment Center, providing classes and individual consultations to help people quit smoking. He is also a principal medical director at Genentech, focusing on developing novel therapies for immunologic disease and improving evaluations and drug approvals for rare diseases. With a medical degree from Tufts University School of Medicine and extensive training at UCSF, Dr. Brunetta is dedicated to advancing patient care and research in the field of pulmonary and critical care medicine.
UCSF Health is a leading medical institution in San Francisco, ranked among the top 10 hospitals in the nation. Committed to providing high-quality patient care, UCSF Health offers a wide range of clinical services and treatments, including breakthroughs in epilepsy management and precision cancer medicine. With a mission to embrace diversity and promote innovation, UCSF Health collaborates with global partners and utilizes cutting-edge technology to improve healthcare outcomes and contribute to a malaria-free world.
Generated from the website